跳至主要内容
临床试验/NCT04034550
NCT04034550进行中(未招募)不适用

Cohort of Hospitalized Patients Suspected of Leptospirosis

Institut National de la Santé Et de la Recherche Médicale, France8 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2021年1月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
200
试验地点
8
主要终点
disease severity

研究概览

简要总结

COLEPT is a prospective interventional study that intends to better inform about leptospirosis, a neglected zoonotic infectious disease. During prospective follow-up of hospitalized acute leptospirosis cases, the participants will be assessed during 1 year for epidemiological, clinical, bacteriological and immunological data. Main intervention consists in blood sampling and biological bank constitution.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
1 Day 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • clinico-biological manifestations compatible with acute leptospirosis OR proven leptospirosis with serological testing or PCR
  • onset of symptoms within 21 days
  • participant benefits of health insurance

排除标准

  • participant's refusal, or refusal from his relatives in case of major incapacity of the eligible participant precluding expression of his will (coma, stay in intensive care unit))

研究组 & 干预措施

hospitalized patients diagnosed with leptospirosis

Experimental

hospitalized patients diagnosed with leptospirosis: 12 months of follow up with biological samples and data collection

干预措施: Blood and urine sampling and blood banking (Other)

结局指标

主要结局

disease severity

时间窗: 0 to 21 days after onset of symptoms

Rate of death or severe organ insuffisiency

次要结局

未报告次要终点

研究者

发起方
Institut National de la Santé Et de la Recherche Médicale, France
申办方类型
Other Gov
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验

Cohort of Hospitalized Patients Suspected of... | 临床试验